The report takes the reader through a comprehensive review
Generic Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering
Generic Pharmaceutical partnering deals.
"FDA is encouraging the
generic industry to investigate whether, and under what circumstances, such problems occur.
On the other hand,
generic medicines are a copy of the formula of the originators and are sold at lower rates as they do not carry out any research work.
As with Truvada,
generic drugs are often substantially cheaper than their branded versions.
About 47.93% of participants agreed that they prescribe
generic medicines when the patient is poor [Figure 3].
Large pharmaceutical companies often spend millions of dollars protecting their patents from
generic competition.
3 August 2016 - Irish drugmaker Allergan plc (NYSE: AGN) has closed an agreement under which Israeli
generics specialist Teva Pharmaceutical Industries Ltd.
The global branded
generics market is expected to grow significantly as large number of pharmaceutical products are going to be off patent within the forecast period.
Frittelli said the ZAR4 billion saving was based on 18% of originator drugs having come off patent, allowing
generic drugs to fill the gap and therefore be available for the taking.
Healthcare company Sanofi (EURONEXT:SAN) (NYSE:SNY) revealed on Thursday that it has launched the approved
generic version of Arava (Leflunomide tablets) 10 mg tablets through its US
generics division, Winthrop.
Generic drugs are those not covered by patent protection and are labeled only by their international nonproprietary or
generic name.